Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Xeris Biopharma Holdings Inc. buy Piper Sandler

Start price
€1.60
10.11.23 / 50%
Target price
€3.74
10.11.24
Performance (%)
99.88%
End price
€3.20
11.11.24
Summary
This prediction ended on 11.11.24 with a price of €3.20. The BUY prediction by Piper_Sandler for Xeris Biopharma Holdings Inc. saw massive gains of 99.88%. Piper_Sandler has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Xeris Biopharma Holdings Inc. 3.203% 3.203% 84.178%
iShares Core DAX® -1.212% 1.925% 17.589%
iShares Nasdaq 100 -4.714% -1.810% 0.450%
iShares Nikkei 225® -2.976% -2.660% 10.156%
iShares S&P 500 -2.744% -0.448% 0.320%

Comments by Piper_Sandler for this prediction

In the thread Xeris Biopharma Holdings Inc. diskutieren
Prediction Buy
Perf. (%) 99.88%
Target price 3.743
Change
Ends at 10.11.24

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its price target lowered by analysts at Piper Sandler from $5.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for XERS provided by MarketBeat

In the thread Trading Xeris Biopharma Holdings Inc.
Prediction Buy
Perf. (%) 99.88%
Target price 3.743
Change
Ends at 10.11.24

Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Piper_Sandler for Xeris Biopharma Holdings Inc.

buy
Xeris Biopharma Holdings Inc.

Start price
Target price
Perf. (%)
€1.64
10.05.24
€2.78
10.05.25
188.96%
11.05.25